← Back to guidelines
Plastic Surgery3 papers

Cicatrix of adenoid

Last edited:

Overview

Nasopharyngeal Cicatrix Syndrome (NCS), also referred to as adenoid cicatrix in horses, is a debilitating condition characterized by chronic inflammation and subsequent scarring within the nasopharyngeal region. This syndrome predominantly affects horses in specific geographic areas, particularly central and southeast Texas, where environmental factors play a significant role in its development. The condition primarily impacts older horses and is closely linked to prolonged exposure to outdoor environments, particularly pasture turnout. Understanding the pathophysiology, epidemiology, clinical presentation, diagnosis, and management of NCS is crucial for effective veterinary intervention and improved outcomes for affected animals.

Pathophysiology

The pathophysiology of NCS involves complex interactions between environmental factors and the upper respiratory microbiota of horses. Studies have highlighted significant alterations in the microbiota of horses with NCS compared to healthy counterparts, suggesting that chronic exposure to environmental irritants or infectious agents may disrupt the normal microbial balance [PMID:34783081]. These disruptions can trigger persistent inflammation, leading to the formation of fibrotic tissue and cicatrices within the nasopharynx. Risk factors identified in affected populations, such as prolonged pasture exposure and age, further support the notion that environmental influences are pivotal in the development of NCS [PMID:23600785]. Chronic irritation from these environmental exposures likely initiates an inflammatory cascade, culminating in the characteristic scarring and airway obstruction seen in affected horses.

Epidemiology

NCS predominantly affects horses residing in central and southeast Texas, indicating a strong regional association that may be linked to specific environmental conditions prevalent in these areas [PMID:34783081]. Housing horses exclusively in stalls appears to confer protection against NCS development, underscoring the role of environmental exposure in disease onset [PMID:34783081]. Epidemiological data reveal a dose-dependent relationship between the duration of pasture turnout and the risk of NCS, with longer periods of outdoor exposure correlating with higher incidence rates [PMID:34783081]. Additionally, age emerges as a significant risk factor, with older horses being more susceptible to NCS [PMID:23600785]. Seasonal trends also emerge, with increased evaluations for NCS observed during warmer months, possibly due to heightened outdoor activity and exposure during these periods [PMID:23600785]. These findings collectively emphasize the importance of environmental management in mitigating the risk of NCS.

Clinical Presentation

The clinical presentation of NCS in horses is multifaceted, evolving from acute inflammatory phases to chronic fibrotic changes that significantly impact respiratory function. Initially, affected horses exhibit signs of acute inflammation, including nasal discharge and pharyngeal swelling, which can be indicative of early-stage infection or irritation [PMID:22380812]. As the condition progresses, these acute symptoms may transition into more chronic manifestations, characterized by the development of web-like scarring within the nasopharynx [PMID:34783081]. This scarring can lead to severe respiratory distress, exercise intolerance, and increased respiratory noise due to airway narrowing and obstruction [PMID:22380812]. Specific clinical signs often correlate with the extent and location of endoscopic lesions: nasal discharge and pharyngeal inflammation are early indicators, while circumferential pharyngeal lesions contribute to exercise intolerance, and combined pharyngeal and laryngeal scarring exacerbate respiratory noise and distress [PMID:22380812]. Early recognition of these signs is crucial for timely intervention and management.

Diagnosis

Diagnosing NCS relies heavily on endoscopic evaluation, which provides critical insights into the nature and extent of nasopharyngeal lesions [PMID:22380812]. Endoscopy allows veterinarians to visualize the characteristic scarring and inflammation patterns that differentiate NCS from other respiratory conditions. Correlating clinical signs with endoscopic findings is essential for accurate diagnosis. For instance, the presence of web-like adhesions and narrowing of the nasopharyngeal passages can be directly linked to the clinical symptoms of respiratory distress and noise [PMID:22380812]. Additionally, while imaging modalities like radiography or CT scans can offer supportive information, they are secondary to endoscopic assessment in confirming the diagnosis of NCS. Proper identification of these lesions through endoscopy guides subsequent management decisions and treatment planning.

Management

The management of NCS is challenging due to the irreversible nature of the fibrotic changes that occur. Severe cases often necessitate drastic interventions, including permanent tracheostomy to ensure adequate airway patency or, in extreme cases, euthanasia when quality of life cannot be maintained [PMID:34783081]. For less severe cases, a tailored approach based on the specific clinical signs and endoscopic findings is recommended. Recognizing the distinct clinical presentations associated with different lesion locations can help in customizing treatment strategies. For example, addressing acute inflammation may involve anti-inflammatory medications and supportive care, while chronic scarring might require more aggressive interventions such as surgical debridement or laser therapy to reduce airway obstruction [PMID:22380812]. Regular monitoring and adjustments in management strategies based on clinical response are essential to optimize outcomes for affected horses.

Key Recommendations

  • Environmental Management: Minimize prolonged pasture turnout, especially in high-risk regions, to reduce exposure to potential environmental irritants and pathogens.
  • Early Detection: Regular endoscopic evaluations, particularly during warmer months when risk is elevated, can aid in early detection and intervention.
  • Tailored Treatment: Customize treatment plans based on the severity and specific manifestations of NCS identified through endoscopic assessment.
  • Supportive Care: Implement supportive care measures, including anti-inflammatory medications and respiratory support, to manage symptoms effectively.
  • Monitoring and Follow-Up: Conduct frequent follow-up evaluations to monitor disease progression and adjust management strategies accordingly, ensuring the best possible quality of life for affected horses.
  • These recommendations aim to mitigate the impact of NCS through proactive environmental controls and timely, targeted clinical interventions.

    References

    1 Rodríguez N, Whitfield-Cargile CM, Chamoun-Emanuelli AM, Hildreth E, Jordan W, Coleman MC. Nasopharyngeal bacterial and fungal microbiota in normal horses and horses with nasopharyngeal cicatrix syndrome. Journal of veterinary internal medicine 2021. link 2 Norman TE, Chaffin MK, Bissett WT, Thompson JA. Risk factors associated with nasopharyngeal cicatrix syndrome in horses. Journal of the American Veterinary Medical Association 2013. link 3 Norman TE, Chaffin MK, Bisset WT, Thompson JA. Association of clinical signs with endoscopic findings in horses with nasopharyngeal cicatrix syndrome: 118 cases (2003-2008). Journal of the American Veterinary Medical Association 2012. link

    Original source

    1. [1]
      Nasopharyngeal bacterial and fungal microbiota in normal horses and horses with nasopharyngeal cicatrix syndrome.Rodríguez N, Whitfield-Cargile CM, Chamoun-Emanuelli AM, Hildreth E, Jordan W, Coleman MC Journal of veterinary internal medicine (2021)
    2. [2]
      Risk factors associated with nasopharyngeal cicatrix syndrome in horses.Norman TE, Chaffin MK, Bissett WT, Thompson JA Journal of the American Veterinary Medical Association (2013)
    3. [3]
      Association of clinical signs with endoscopic findings in horses with nasopharyngeal cicatrix syndrome: 118 cases (2003-2008).Norman TE, Chaffin MK, Bisset WT, Thompson JA Journal of the American Veterinary Medical Association (2012)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG